We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1051
Kohlberg Kravis Roberts & Co
New York
-$8.59M -58,139 Closed
SCM
1052
Sandler Capital Management
New York
-$6.93M -46,890 Closed
PP
1053
PDT Partners
New York
-$6.87M -46,500 Closed
OI
1054
Oakbrook Investments
Illinois
-$6.52M -44,150 Closed
HCMT
1055
Highland Capital Management (Texas)
Texas
-$4.03M -27,300 Closed
VAM
1056
Visium Asset Management
New York
-$3.82M -25,841 Closed
TI
1057
Trexquant Investment
Connecticut
-$3.6M -24,400 Closed
PP
1058
Paloma Partners
Connecticut
-$3.18M -21,511 Closed
TCM
1059
Traynor Capital Management
Pennsylvania
-$1.28M -21,043 Closed
Walleye Trading
1060
Walleye Trading
New York
-$2.9M -18,789 Closed
ICRM
1061
Insight Capital Research & Management
California
-$2.64M -17,851 Closed
Arrowstreet Capital
1062
Arrowstreet Capital
Massachusetts
-$2.28M -15,400 Closed
OIM
1063
Orca Investment Management
Oregon
-$2.04M -13,835 Closed
TWA
1064
Tillar-Wenstrup Advisors
Ohio
-$1.98M -13,385 Closed
QAM
1065
Quantres Asset Management
Cayman Islands
-$1.54M -10,400 Closed
Twin Tree Management
1066
Twin Tree Management
Texas
-$1.56M -10,097 Closed
MF
1067
Magnetar Financial
Illinois
-$1.48M -10,000 Closed
EAMA
1068
EFG Asset Management (Americas)
Florida
-$1.49M -9,961 Closed
TH
1069
Timber Hill
Connecticut
-$1.33M -8,604 Closed
SI
1070
Scharf Investments
California
-$1.15M -7,810 Closed
Squarepoint
1071
Squarepoint
New York
-$1.14M -7,729 Closed
HMS
1072
Hanseatic Management Services
New Mexico
-$968K -6,550 Closed
ARTA
1073
A.R.T. Advisors
New York
-$953K -6,455 Closed
Parallax Volatility Advisers
1074
Parallax Volatility Advisers
California
-$991K -6,430 Closed
TI
1075
Turner Investments
Pennsylvania
-$752K -5,090 Closed

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.